Plain English summary not yet available
The full original text is available below. Check back soon as we process this bill.
II
116TH CONGRESS
1ST SESSION
S. 616
To impose user fees on manufacturers and importers of electronic nicotine
delivery systems.
IN THE SENATE OF THE UNITED STATES
FEBRUARY 28, 2019
Mrs. SHAHEEN introduced the following bill; which was read twice and
referred to the Committee on Health, Education, Labor, and Pensions
A BILL
To impose user fees on manufacturers and importers of
electronic nicotine delivery systems.
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled,
2
SECTION 1. SHORT TITLE.
3
This Act may be cited as the ‘‘E-Cigarette Youth
4
Protection Act’’.
5
SEC. 2. USER FEES RELATING TO ELECTRONIC NICOTINE
6
DELIVERY SYSTEMS.
7
(a) IN GENERAL.—Chapter IX of the Federal Food,
8
Drug, and Cosmetic Act (21 U.S.C. 387 et seq.) is amend-
9
ed by inserting after section 919 the following:
10
VerDate Sep 11 2014
03:30 Mar 07, 2019
Jkt 089200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\S616.IS
S616
kjohnson on DSK79L0C42 with BILLS
2
•S 616 IS
‘‘SEC. 919A. USER FEES RELATING TO ELECTRONIC NICO-
1
TINE DELIVERY SYSTEMS.
2
‘‘(a) ESTABLISHMENT OF QUARTERLY FEE.—Begin-
3
ning on the date of enactment of the E-Cigarette Youth
4
Protection Act, the Secretary shall in accordance with this
5
section assess user fees on, and collect such fees from,
6
each manufacturer and importer of electronic nicotine de-
7
livery systems. The fees shall be assessed and collected
8
with respect to each quarter of each fiscal year, and the
9
total amount assessed and collected for a fiscal year shall
10
be the amount specified in subsection (b)(1) for such year,
11
subject to subsection (c).
12
‘‘(b) ASSESSMENT OF USER FEE.—
13
‘‘(1) AMOUNT
OF
ASSESSMENT.—The total
14
amount of user fees authorized to be assessed and
15
collected under subsection (a) for a fiscal year is the
16
following, as applicable to the fiscal year involved:
17
‘‘(A) For fiscal year 2020, the greater of—
18
‘‘(i) $150,000,000; or
19
‘‘(ii) 2 percent of the total value of
20
manufacturer sales of electronic nicotine
21
delivery systems in the United States in
22
fiscal year 2019.
23
‘‘(B) For fiscal year 2021 and each fiscal
24
year thereafter, the greater of—
25
VerDate Sep 11 2014
03:30 Mar 07, 2019
Jkt 089200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\S616.IS
S616
kjohnson on DSK79L0C42 with BILLS
3
•S 616 IS
‘‘(i) the amount described in subpara-
1
graph (A), increased by the percentage in-
2
crease in the Consumer Price Index be-
3
tween 2020 and the applicable year; or
4
‘‘(ii) 2 percent of the total value of
5
manufacturer sales of electronic nicotine
6
delivery systems in the United States in
7
the previous fiscal year.
8
‘‘(2) DETERMINATION OF USER FEE BY COM-
9
PANY.—
10
‘‘(A) IN GENERAL.—The total user fee to
11
be paid by each manufacturer or importer of
12
electronic nicotine delivery systems shall be de-
13
termined for each quarter by multiplying—
14
‘‘(i) such manufacturer’s or importer’s
15
percentage share of the total electronic nic-
16
otine delivery system market in the United
17
States; by
18
‘‘(ii) the portion of the user fee
19
amount for the current quarter to be as-
20
sessed on all manufacturers and importers
21
under paragraph (1).
22
‘‘(B) NO FEE IN EXCESS OF PERCENTAGE
23
SHARE.—No manufacturer or importer of elec-
24
tronic nicotine delivery systems shall be re-
25
VerDate Sep 11 2014
03:30 Mar 07, 2019
Jkt 089200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\S616.IS
S616
kjohnson on DSK79L0C42 with BILLS
4
•S 616 IS
quired to pay a user fee in excess of the per-
1
centage share of the total electronic nicotine de-
2
livery system market of the manufacturer or
3
importer.
4
‘‘(3) TIMING OF ASSESSMENT.—The Secretary
5
shall notify each manufacturer and importer of elec-
6
tronic nicotine delivery systems subject to this sec-
7
tion of the amount of the quarterly assessment im-
8
posed on such manufacturer or importer under this
9
subsection for each quarter of each fiscal year. Such
10
notifications shall occur not later than 30 days prior
11
to the end of the quarter for which such assessment
12
is made, and payments of all assessments shall be
13
made by the last day of the quarter involved.
14
‘‘(4) CALCULATION OF MARKET SHARE.—Be-
15
ginning not later than fiscal year 2020, and for each
16
subsequent fiscal year, the Secretary shall ensure
17
that the Food and Drug Administration is able to
18
determine—
19
‘‘(A) the annual amount of total sales in
20
the electronic nicotine delivery system market of
21
the United States; and
22
‘‘(B) the applicable percentage shares
23
under paragraph (2)(A).
24
‘‘(c) CREDITING AND AVAILABILITY OF FEES.—
25
VerDate Sep 11 2014
03:30 Mar 07, 2019
Jkt 089200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\S616.IS
S616
kjohnson on DSK79L0C42 with BILLS
5
•S 616 IS
‘‘(1) IN GENERAL.—Fees authorized under sub-
1
section (a) shall be collected and available for obliga-
2
tion only to the extent and in the amount provided
3
in advance in appropriations Acts. Such fees are au-
4
thorized to remain available until expended. Such
5
sums as may be necessary may be transferred from
6
the Food and Drug Administration salaries and ex-
7
penses appropriation account without fiscal year lim-
8
itation to such appropriation account for salaries
9
and expenses with such fiscal year limitation.
10
‘‘(2) AUTHORIZATION
OF
APPROPRIATIONS.—
11
For fiscal year 2021 and each subsequent fiscal
12
year, there is authorized to be appropriated for fees
13
under this section an amount equal to the amount
14
specified in subsection (b)(1) for the fiscal year.
15
‘‘(d) COLLECTION OF UNPAID FEES.—In any case
16
where the Secretary does not receive payment of a fee as-
17
sessed under subsection (a) within 30 days after it is due,
18
such fee shall be treated as a claim of the United States
19
Government subject to subchapter II of chapter 37 of title
20
31, United States Code.
21
‘‘(e) APPLICABILITY TO FISCAL YEAR 2020.—If the
22
date of enactment of the E-Cigarette Youth Protection Act
23
occurs during fiscal year 2020, subject to subsection (c),
24
for the quarter following the quarter in which such date
25
VerDate Sep 11 2014
03:30 Mar 07, 2019
Jkt 089200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\S616.IS
S616
kjohnson on DSK79L0C42 with BILLS
6
•S 616 IS
of enactment occurs, the full quarterly fee amounts shall
1
be assessed and collected.’’.
2
(b) ENFORCEMENT.—
3
(1) IN GENERAL.—Section 902(4) of the Fed-
4
eral Food, Drug, and Cosmetic Act (21 U.S.C.
5
387b(4)) is amended by inserting ‘‘, or the manufac-
6
turer or importer of electronic nicotine delivery sys-
7
tems fails to pay a user fee assessed to such manu-
8
facturer or importer pursuant to section 919A by
9
the date specified in section 919A or by the 30th
10
day after final agency action on a resolution of any
11
dispute as to the amount of such fee’’ before the
12
semicolon.
13
(2) EFFECTIVE DATE.—The amendment made
14
by paragraph (1) shall take effect on the later of Oc-
15
tober 1, 2021, or the date of enactment of this Act.
16
(c) DEFINITION.—Section 900 of the Federal Food,
17
Drug, and Cosmetic Act (21 U.S.C. 387) is amended—
18
(1) by redesignating paragraphs (8) through
19
(22) as paragraphs (9) through (23), respectively;
20
and
21
(2) by inserting after paragraph (7) the fol-
22
lowing:
23
VerDate Sep 11 2014
03:30 Mar 07, 2019
Jkt 089200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\S616.IS
S616
kjohnson on DSK79L0C42 with BILLS
7
•S 616 IS
‘‘(8) ELECTRONIC
NICOTINE
DELIVERY
SYS-
1
TEM.—The term ‘electronic nicotine delivery sys-
2
tem’—
3
‘‘(A) means any electronic device that de-
4
livers nicotine, flavor, or another substance via
5
an aerosolized solution to the user inhaling
6
from the device (including e-cigarettes, e-hook-
7
ah, e-cigars, vape pens, advanced refillable per-
8
sonal vaporizers, and electronic pipes) and any
9
component, liquid, part, or accessory of such a
10
device, whether or not sold separately; and
11
‘‘(B) does not include a product that—
12
‘‘(i) is approved by the Food and
13
Drug Administration for sale as a tobacco
14
cessation product or for another thera-
15
peutic purpose; and
16
‘‘(ii) is marketed and sold solely for a
17
purpose described in clause (i).’’.
18
Æ
VerDate Sep 11 2014
03:30 Mar 07, 2019
Jkt 089200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6301
E:\BILLS\S616.IS
S616
kjohnson on DSK79L0C42 with BILLS
Important: This plain English summary was generated by AI and is provided for informational purposes only.
It is not legal advice. Always consult the official bill text on Congress.gov
or a qualified attorney for legal matters.